Advertisement

Alere Inc., the Waltham life sciences firm formerly known as Inverness Medical Innovations Inc., plans to raise $350 million through a private placement of senior subordinated notes, with proceeds being used for working capital and general purposes.

According to officials at Alere (NYSE: ALR) the notes will be due in 2018. The company did not disclose the purchaser of the notes, or identify any manager of the sale.

SOURCE

Advertisement
Advertisement